Pathology AI Tools

Quantifies tissue and tumour characteristics on whole-slide pathology images using customisable deep-learning models.

Foundation-model platform that analyzes the tumor microenvironment in digitized H&E slides for biomarker and target discovery — research use only, not yet cleared for diagnosis.

AI support for breast pathology assessment, including H&E/IHC review and biomarker quantification for pathologists.

Pre-screens prostate biopsy slides and provides Gleason grading and perineural-invasion insights to pathologists.

CE-IVD marked AI portfolio that automates IHC biomarker quantification (HER2, Ki-67, PD-L1, and more) for breast, lung, and other cancers.

Flags suspicious cancer foci on digitised prostate biopsy slides to support pathologists' primary diagnosis.

Digital pathology platform for viewing, interpreting, and managing whole-slide images to support primary diagnosis.

Automates quantification of IHC biomarkers such as Ki-67 and tumour-infiltrating lymphocytes on digital pathology slides.

Runs automated AI biomarker analysis (HER2, PD-L1, Ki-67) within an integrated digital pathology case-management platform.